Currently, there are 157.29M common shares owned by the public and among those 106.84M shares have been available to trade.
The company’s stock has a 5-day price change of 44.12% and 48.48% over the past three months. BBAI shares are trading 14.49% year to date (YTD), with the 12-month market performance up to 38.42% higher. It has a 12-month low price of $1.16 and touched a high of $4.80 over the same period. BBAI has an average intraday trading volume of 4.86 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 35.06%, 45.82%, and 41.95% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of BigBear.ai Holdings Inc (NYSE: BBAI) shares accounts for 9.90% of the company’s 157.29M shares outstanding.
It has a market capitalization of $686.83M and a beta (3y monthly) value of 3.26. The earnings-per-share (ttm) stands at -$0.90. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.75% over the week and 8.80% over the month.
Earnings per share for the fiscal year are expected to decrease by -82.50%, and 73.97% over the next financial year.
Looking at the support for the BBAI, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on January 09, 2024, with the firm’s price target at $3. TD Cowen coverage for the BigBear.ai Holdings Inc (BBAI) stock in a research note released on October 02, 2023 offered a Market Perform rating with a price target of $2. Oppenheimer on their part issued Outperform rating on March 28, 2022.
